Literature DB >> 3123211

Language lateralization in children with benign partial epilepsy.

M Piccirilli1, P D'Alessandro, C Tiacci, A Ferroni.   

Abstract

To investigate the relationship between epilepsy and hemispheric asymmetries for language, a dual-task procedure was used to assess language lateralization in children with benign rolandic childhood epilepsy. In the sample selection, care was taken to include factors believed to influence both the mental capabilities of epileptic patients and the individual functional cerebral organization. Results suggest that the interhemispheric prevalence pattern is related to the focus site. Controls as well as epileptic patients with a right hemispheric focus showed the expected left language lateralization; conversely, children with a left unilateral focus showed a different pattern of functional representation, suggesting an involvement of the right hemisphere in language mechanisms. It is emphasized that this atypical cerebral organization is found in subjects with no structural lesion and no therapy. It seems likely that the presence of a focal epileptic activity itself can alter the cerebral mechanisms underlying cognitive functions. A relationship between this modified hemispheric specialization and subtle neuropsychological dysfunctions observed in the children with focal epilepsy is suggested.

Entities:  

Mesh:

Year:  1988        PMID: 3123211     DOI: 10.1111/j.1528-1157.1988.tb05092.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

1.  Neuropsychological features of benign partial epilepsy in children.

Authors:  P D'Alessandro; M Piccirilli; C Tiacci; A Ibba; M Maiotti; T Sciarma; A Testa
Journal:  Ital J Neurol Sci       Date:  1990-06

2.  Evidence for a neurophysiologic auditory deficit in children with benign epilepsy with centro-temporal spikes.

Authors:  A Liasis; D E Bamiou; S Boyd; A Towell
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.